Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using cardiac imaging to improve risk assessment in Takotsubo syndrome

Official title: Exploring the eVolution in prognOstic capabiLity of mUlti-sequence Cardiac magneTIc resOnance in patieNts Affected by Takotsubo Cardiomyopathy

Run by University of Cagliari · NCT06277297 · Data updated 2026-11-12

This study is testing a new way to predict how well patients with Takotsubo syndrome will do in the hospital and over time by using heart imaging and comparing it to current methods.

More Magnetic Resonance Imaging trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment350 (estimated)
SponsorUniversity of Cagliari
Academic / other
Locations1 site (Cagliari, Italy)
StatusRecruiting
StartedNovember 9, 2022
Main results expectedNovember 2026
Study endsNovember 2032
Registry record updatedJune 8, 2025
Trial IDNCT06277297 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adult patients over 18 years old diagnosed with Takotsubo syndrome who have available clinical and imaging data.

Probably not a fit

Patients under 18 years old, those with preexisting cardiomyopathies, or those lacking necessary imaging examinations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry aims to develop a comprehensive clinical and imaging score that enhances risk stratification for patients diagnosed with Takotsubo syndrome. It will incorporate data from echocardiography and cardiac magnetic resonance imaging (CMR) to predict both in-hospital and long-term outcomes. The study will also compare the new risk stratification score with existing scores and explore the use of machine learning models for improved outcome prediction. By addressing the current gaps in prognostic assessment, this initiative seeks to optimize the management of Takotsubo syndrome patients.

Why it matters

Potential benefit: If successful, this study could provide a more reliable predictive tool for managing patients with Takotsubo syndrome, potentially improving their outcomes.

How similar studies have gone: While CMR has been studied for diagnostic purposes in Takotsubo syndrome, the incorporation of CMR data into prognostic scoring is a novel approach that has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Takotsubo syndrome diagnosis (according to Position Statement of the European Society of Cardiology Heart Failure Association)
* Adult patients ( \> 18y old)
* Availability at baseline of clinical variables, standard transthoracic echocardiography, and cardiovascular magnetic resonance acquisition

Exclusion Criteria:

* \<18 y old
* Lack of transthoracic echocardiography and cardiovascular magnetic resonance examinations
* Preexisting cardiomyopathies
* Previous myocardial infarction
* Suspected or known prior irreversible myocardial damage
* Valvular heart disease

Where it's running

  • University of Cagliari
    Cagliari, Italy, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.